2003Journal of Pediatric PharmacyRequires access

Clinical effects of cefaclor on pediatric bacterial respiratory infection

Shi Yuan

Open publisher page 0 citations

Abstract

Objective: To investigate the clinical effects of cefaclor on pediatric bacterial respiratory infection. Methods: 460 children with bacterial respiratory infection were treated with cefaclor taken orally for 7 days. Results: The total effects were 91. 30%, with the effects of 100% on acute tonsil inflammation, 95. 00% on acute bronchitis, and 81. 88% on acute bronchial pneumonia. Conclusions: When taken orally, cefaclor has still a significant effect on pediatric bacterial respiratory infection.

About this research paper

What this paper is about

Objective: To investigate the clinical effects of cefaclor on pediatric bacterial respiratory infection. Methods: 460 children with bacterial respiratory infection were treated with cefaclor taken orally for 7 days. Results: The total effects were 91. 30%, with the effects of 100% on acute tonsil inflammation, 95. 00% on acute bronchitis, and 81. 88% on acute bronchial pneumonia. Conclusions: When taken orally, cefaclor has still a significant effect on pediatric bacterial respiratory infection.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate the clinical effects of cefaclor on pediatric bacterial respiratory infection. Methods: 460 children with bacterial respiratory infection were treated with cefaclor taken orally for 7 days. Results: The total effects were 91. 30%, with the effects of 100% on acute tonsil inflammation, 95. 00% on acute bronchitis, and 81. 88% on acute bronchial pneumonia. Conclusions: When taken orally, cefaclor has still a significant effect on pediatric bacterial respiratory infection.

Key concepts: Cefaclor, Medicine, Bronchitis, Pneumonia, Respiratory system, Tonsil, Bacterial pneumonia, Respiratory infection

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical effects of cefaclor on pediatric bacterial respiratory infection — Research Paper | ScholarLens